Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis

J Clin Oncol. 2017 Mar 10;35(8):923. doi: 10.1200/JCO.2016.71.0715. Epub 2017 Jan 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anthracyclines*
  • Breast Neoplasms*
  • Cardiotoxicity
  • Humans
  • Obesity
  • Risk Factors
  • Trastuzumab

Substances

  • Anthracyclines
  • Trastuzumab